new glp-1 agonists Five Unexpected Uses for Receptor Machine learning designs new GCGR/GLP-1R

Sotagliflozin and kidney outcomes, kidney function, and albuminuria in type 2 diabetes and CKD: A secondary analysis of the SCORED trial

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled parallel-group study

In older adults there is an association between weight loss and all-cause mortality, especially in men who lose more than 10% of body weight, Ganta says

Patients consuming significantly fewer calories may not meet requirements for essential micronutrients, including B vitamins, iron, and vitamin D, all of which play crucial roles in energy metabolism

Dr Hamdy is enthusiastic about the pharma industry's investment in new products, and the growing insight into its pathophysiology

doi: 10.3390/cimb45060288 [DOI] [PMC free article] [PubMed] [Google Scholar] 58